ASAbdalrahman Salah Shehata

Abdalrahman Salah Shehata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdalrahman Salah Shehata has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Indocyanine green (ICG) guided thyroidectomy versus conventional thyroidectomy and the impact on parathyroid function preservation: an updated GRADE-assessed systematic review and meta-analysis

    by Ahmed Wael Moftah, Abdo Mohamed Abdalhy, Hammam Majed Alsousi, Abdalrahman Salah Shehata, Mahmoud Ashraf Hussein, Yasser Ashraf Gamal, Myame Ayman, Israa A. Solah, Hebatalla Aly

    Background: Thyroidectomy carries a significant risk of parathyroid gland injury, with transient hypoparathyroidism occurring in 15–50% of cases and permanent hypoparathyroidism in up to 5%, resulting in lifelong morbidity. Near-infrared (NIR) autofluorescence imaging combined with indocyanine green (ICG) fluorescence angiography has emerged as an intraoperative adjunct for parathyroid identification and perfusion assessment, but its comparative efficacy over conventional white-light surgery remains to be comprehensively quantified. Methods: A systematic search across five databases through January 2026 identified randomized controlled trials and observational studies comparing NIR autofluorescence with ICG imaging versus conventional thyroidectomy without fluorescence guidance. Outcomes included inadvertent parathyroid removal, permanent and transient hypoparathyroidism, permanent and transient hypocalcemia, postoperative parathyroid hormone (PTH) levels, postoperative serum calcium levels, and operative time. Meta-analysis utilized a random-effects model to calculate pooled risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs). Certainty of evidence was assessed using the GRADE approach. Results: Eleven studies encompassing 2,203 patients (ICG: n = 897; Control: n = 1,306) were included. ICG-guided NIR imaging significantly reduced inadvertent parathyroid removal (RR 0.43, 95% CI 0.30–0.61, p = 0.002; I²=0%) and permanent hypocalcemia (RR 0.25, 95% CI 0.17–0.37, p = 0.004; I²=0%). A non-significant trend toward reduced permanent hypoparathyroidism was observed under our pre-specified random-effects model (RR 0.45, 95% CI 0.20–1.02, p = 0.054). A post-hoc sensitivity analysis using a fixed-effect model yielded a statistically significant result (RR 0.50, 95% CI 0.36–0.71, p < 0.001); however, this finding should be interpreted with caution, as it did not correspond to our primary pre-specified analytical approach. ICG guidance was associated with significantly higher postoperative PTH levels (MD 5.45 pg/mol, 95% CI 0.26–10.64, p = 0.042) and serum calcium levels (MD 0.06 mmol/L, 95% CI 0.01–0.11, p = 0.033). No significant differences were noted in transient hypoparathyroidism (RR 0.56, 95% CI 0.21–1.53, p = 0.185) or transient hypocalcemia (RR 0.67, 95% CI 0.33–1.34, p = 0.182), both characterized by substantial heterogeneity (I²=78.4% and 75.4%, respectively). Operative time was comparable between groups (MD 0.08 min, 95% CI − 18.25 to 18.42, p = 0.989). Conclusions: NIR autofluorescence with ICG imaging is associated with a reduction in inadvertent parathyroid removal and permanent hypocalcemia, supported by high and moderate certainty evidence respectively, along with improvements in postoperative PTH and calcium levels (moderate certainty). Evidence for benefit in permanent hypoparathyroidism was directionally favorable but of low certainty, and findings for transient hypoparathyroidism and transient hypocalcemia were inconclusive, rated low to very low certainty due to substantial heterogeneity. These findings support ICG-guided NIR imaging as a promising intraoperative adjunct, with the strongest evidence for reducing inadvertent gland removal and permanent hypocalcemia specifically, rather than uniform benefit across all parathyroid-related outcomes. Future large-scale randomized trials with standardized imaging protocols, blinded outcome assessment, and extended follow-up are needed to resolve heterogeneity in transient outcomes and confirm long-term benefits in high-risk surgical populations.

  • Open Access

    Association between behavioral addiction and psychological disorders among medical students in Egypt, Sudan, and Libya: a cross-sectional study

    by Abdelmonam M. Hagag, Abdalrahman Salah Shehata, Athar Mohamed Abdelhamed, Gsemallah Abdo Ahmed, Omar A. Ghanem, Ayoub Akwaisah, Mohamed Abdelghani

    We aimed to assess the prevalence of problematic internet use, gaming disorder symptoms, or problematic pornography consumption among medical students in Egypt, Sudan, and Libya, and their associations with psychological disturbances. A cross-sectional study was conducted via an online questionnaire. We used the Problematic Internet Use Scale (IAT), the Internet Gaming Disorder Scale–Short-Form (IGDS9-SF), and the Problematic Pornography Consumption Scale (PPCS). Chi-square tests were used to assess the variation between participants on the basis of their nationality. Multivariable multiple linear regression was used to assess the associations between behavioral addiction and psychological disorders and other confounders. A total of 1284 patients completed the questionnaire. The prevalence rates were 28.82%, 6.78%, and 7.55% for problematic internet use, gaming disorder symptoms, or problematic pornography consumption, respectively. Compared with other students, Egyptian medical students had a significant increase in all behavioral addictions. A positive association between increased behavioral addictions and anxiety or depression was observed. Stress was positively associated with problematic internet use and negatively associated with gaming disorder and pornography addiction. Sleeping less than 6 h was negatively associated with gaming disorder symptoms or problematic pornography consumption, whereas sleeping more than 9 h was positively associated with gaming disorder symptoms or problematic pornography consumption. Our study revealed a moderate level of problematic internet use, with a low level of gaming disorders and pornography addiction, alongside significant regional variation in prevalence.


  • Open Access

    Factors influencing HIV testing among women in Mozambique: insights from the 2022/23 demographic and health survey

    by Amr Ahmed Aly Ibrahim, Abdalrahman Salah Shehata, Sara Hosny El-Farargy, Moaz Yasser Darwish, Ahmed Reda Bahr, Karim Samir Attia, Omar Abbas, Mahmoud Shaaban Abdelgalil

    Background: Mozambique bears a high HIV burden, with low testing uptake among young women. This study analyzes socio-demographic and behavioral factors influencing HIV testing among women aged 15–49, using data from the 2022/23 Demographic and Health Survey (DHS). Methods: A secondary analysis of the Mozambique DHS 2023 dataset was performed using R (Version 4.4.2, R Core Team) to explore factors associated with HIV testing uptake. Variables including age, education, marital status, geographic location, and socioeconomic indicators were analyzed. Descriptive statistics were calculated, and associations were evaluated using a modified Poisson regression model with robust standard errors to estimate risk ratios. Both univariate and multivariable models were used to identify significant predictors, accounting for the survey’s complex design. Results: The analysis included 13,183 women aged 15–49 years, of whom 67.56% reported having ever been tested for HIV. Multivariate analysis revealed that older age, higher educational attainment, greater household wealth, living with a partner, recent health facility visits, and internet use were significantly associated with higher likelihood of HIV testing. Conversely, rural residence was significantly associated with lower likelihood of testing. Regional variation in testing uptake was also observed, with most provinces showing significantly higher testing rates compared to Niassa. Variables including religion, health insurance, newspaper reading, and television viewing were not independently associated with HIV testing after adjustment for other covariates (all p > 0.05). Conclusions: Mozambique must prioritize expanding HIV testing in rural areas by enhancing healthcare access and community outreach. Promoting awareness through digital platforms and integrating HIV education into public programs can further improve testing uptake. Strengthening education and healthcare services is vital to achieving better prevention and early treatment outcomes.

  • Open Access

    Association of Sodium–Glucose Cotransporter 2 Inhibitor Use With Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and GRADE‐Assessed Meta‐Analysis

    by Ahmed Adel Mohamed, Batool Husain Husain, Tammam Khaled Dali, Mostafa Elsayed Ahmed, Ghaida Al Shawawreh, Ali Samir Galal, Mahmoud Abdelwahab Moussa, Abdallah M. Hibysh, Abdalrahman Salah Shehata, Youssef Ramadan, et al.

    Background: Patients undergoing transcatheter aortic valve implantation (TAVI) remain at risk of adverse cardiovascular and renal outcomes despite procedural advancements. Sodium–glucose cotransporter 2 (SGLT2) inhibitors have demonstrated cardiovascular and renal benefits across various patient populations; however, their role in patients undergoing TAVI remains unclear. This study is aimed at evaluating the association between SGLT2 inhibitor use and clinical outcomes in this population. Methods: We conducted a systematic review and meta‐analysis comparing SGLT2 inhibitors versus non‐SGLT2 inhibitors or standard care in patients undergoing TAVI. Major databases were searched through March 2026, with Embase updated through June 2026. Pooled analyses were performed using random‐effects models to calculate risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs). Results: Five studies involving 6111 patients (SGLT2 inhibitors: n = 2933; control: n = 3178) were included. In primary random‐effects models, SGLT2 inhibitors were associated with lower all‐cause mortality (RR 0.68, 95% CI 0.48–0.97, p = 0.03), heart failure (HF) hospitalization (RR 0.62, 95% CI 0.42–0.90, p = 0.01), and major adverse cardiovascular events (RR 0.68, 95% CI 0.48–0.96, p = 0.03). However, in REML/Hartung–Knapp sensitivity analyses, CIs crossed the null for all‐cause mortality, HF hospitalization, MACE, and pooled hazard ratios. Mortality benefits were absent at 6 and 12 months and in the randomized trial but persisted in low left ventricular ejection fraction (RR 0.56, 95% CI 0.35–0.89, p = 0.01). No significant differences occurred in acute kidney injury, urinary tract infections, or echocardiographic parameters. Conclusion: SGLT2 inhibitor use was associated with lower all‐cause mortality and HF hospitalization after TAVI, but the evidence is limited by observational designs, heterogeneity, and low certainty for several outcomes. Further randomized trials are required.